跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
M-LANSOPRAZOLE
Authorized
STANDARD
M-LANSOPRAZOLE
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
03c1f9a10b9cd0b5
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
03c1f9a10b9cd0b5
Drug Approval Canada Name
M-LANSOPRAZOLE
Product Name
M-LANSOPRAZOLE
Status
Marketed
Status Date
2019-12-13
Original Market Date
2019-12-13
Din
02489813
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC03 LANSOPRAZOLE
Atc Name
a 02 bc 03
Aig Number
0127666001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
LANSOPRAZOLE
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
03c1f9a10b9cd0b5
Type
Standard
Back to Health Canada Approvals
M-LANSOPRAZOLE - Health Canada Drug Approval Details